Exhibit A

Joint Filing Agreement

 

The undersigned hereby agree that this Statement on Schedule 13G/A with respect to the beneficial ownership of shares of Common Stock of Trevi Therapeutics, Inc. is filed jointly, on behalf of each of them.

 

 

Rosalind Advisors, Inc.

By: _____________________________

Name: Steven Salamon

Title: President

 

Rosalind Master Fund L.P.

By: _____________________________

Name: Mike McDonald

Title: Director, Rosalind (Cayman) Ltd. (as General Partner to Rosalind Master Fund)

 

By: _____________________________

Name: Steven Salamon

 

NYC#: 139632.2

Grafico Azioni Trevi Therapeutics (NASDAQ:TRVI)
Storico
Da Gen 2025 a Feb 2025 Clicca qui per i Grafici di Trevi Therapeutics
Grafico Azioni Trevi Therapeutics (NASDAQ:TRVI)
Storico
Da Feb 2024 a Feb 2025 Clicca qui per i Grafici di Trevi Therapeutics